News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lefebvre Eric
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 43,750 shares
@ $0 |
|
| 04/03/2023 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 11,245 shares
@ $26.5209, valued at
$298.2k
|
|
| 03/31/2023 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 21,874 shares
@ $0 |
|
| 01/27/2023 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 57,000 shares
@ $0
Granted 80,000 options to buy
@ $34.65, valued at
$2.8M
|
|
| 01/27/2023 |
4
| Lefebvre Eric (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $7.8, valued at
$195k
|
|
| 01/25/2023 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 67,500 shares
@ $34.4834, valued at
$2.3M
|
|
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2022 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 5,000 shares
@ $25.0482, valued at
$125.2k
|
|
| 07/13/2022 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 3,000 shares
@ $20, valued at
$60k
|
|
| 03/21/2022 |
4
| Lefebvre Eric (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 115,000 options to buy
@ $3.21, valued at
$369.2k
|
|
| 03/21/2022 |
3
| Lefebvre Eric (Director) has filed a Form 3 on CymaBay Therapeutics, Inc. |
| 02/02/2022 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 140,000 options to buy
@ $11.86, valued at
$1.7M
|
|
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 73,250 options to buy
@ $26.5, valued at
$1.9M
|
|
| 12/21/2020 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 6,788 shares
@ $26.17, valued at
$177.6k
Sold 5,712 shares
@ $26.98, valued at
$154.1k
|
|
| 06/02/2020 |
3
| Lefebvre Eric (Chief Medical Officer) has filed a Form 3 on PLIANT THERAPEUTICS, INC. |
| 11/03/2016 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on Tobira Therapeutics, Inc.|
Txns:
| Disposed/sold 79,287 options to buy
@ $3.51, valued at
$278.3k
Disposed/sold 100,000 options to buy
@ $14, valued at
$1.4M
Disposed/sold 101,000 options to buy
@ $7.91, valued at
$798.9k
|
|
|
|